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Introduction. Appearance of the new terminology such as “endothelial 
dysfunction” and “chronic systemic inflammation” has designated a new round 
in the study of essential hypertension (EH), namely – to defining the role of the 
immune inflammatory mechanisms in the development and progression of 
vascular pathology [1, 6, 8]. It should be noted that the peculiarity of internal 
pathology at present time is its comorbidity  [2, 9, 10], besides EH comorbidity 
worsens disease on the whole [3, 4]. Combination of EH with duodenal peptic 
ulcer (DPU) is frequent. It can complicate diagnostics, modify clinical 
symptoms and worsen treatment quality [7]. The foregoing formed basis of this 
study. The study aimed to identify the features of the changes of the cytokine 
profile and endothelial function in patients with EH and comorbid DPU. 
Materials and methods. Totally 65 patients (35 males and 30 females) 
with second stage of EH (medication control) were examined; 32 of them had 
isolated EH (comparison group) and 33 patients (main group) had EH in 
combination with DPU (remission period). The study population had a mean age 
of 44,3±2,9 years. Reference indicators were obtained while studying 23 
practically healthy individuals, sex and age of whome did not differentiate with 
those of examined patients. 
Spectrophotometrical method was used to evaluate the indices of 
endothelial function: the level of ultimate stable metabolites of nitrogen oxide 
(Griss reagent) – nitrites (NО2), nitrates (NО3),their total content (NОх) in blood 
serum and risk-marker of thrombogenic complications (according to ristomycin-
induced platelet aggregation (RIPA) [5, 11]. Blood test for pro- (TNF-α, IL-1β, 
IL-6) and anti-inflammatory (IL-10) cytokines (Ck) was conducted by 
immunoenzyme method. 
Results. Present study revealed that patients with comorbid EH 
(compared to reference data) had 1.5 times decreased level of NО2, 1.6 times 
decreased level of NО3 and 1.6 times decreased NОх (р<0.001 in all cases). 
Unlike patients with isolated course of EH, in EH comorbidity RIPA not only 
exceeded 1.45 times reference data (р<0.001) and 1.12 times index of the 
comparison group(p<0.05), but also the physiological threshold of this index on 
the whole, and, moreover, the inverse correlation was found between RIPA and 
NOх (r = -0.27; p<0.01). 
In patients of the main group an essentially increased level (in comparison 
with reference data) of Ck was revealed - TNF-α (2.6 times higher; р<0.001), 
IL-1β (2.3 times higher; р<0.001), IL-6 ( 1.6 higher; р<0.001) и IL-10 (1.3 
higher; р<0.05). Noteworthy that absolute content of proinflamamtory Ck in the 
patients of the main group had been higher than in the comparison group: TNF-α 
– 1.5 times higher (р<0.001), IL-1β – 1.4 times higher (р<0.05), IL-6 – 1.3 times 
higher (р<0.05). At the same time, TNF-α/IL-10 index (almost twice higher 
(р<0.001) than in the reference data) was 1.3 times higer than in comparison 
group (р<0.01); IL-1β/IL-10 and IL-6/IL-10 indices exceeded reference data 
values 1.9 times higher (р<0.001) and 1.3 times higher (р<0.05), respectively. 
Patients of the main group had negative correllations between TNF-α and NOх, 
IL-1β and NOх (r = -0.30 and r = -0.28 accordingly; p<0.01) and their severity 
was higher than in patients of comparison group(r = -0.27 and r = -0.24 
accordingly; p<0.01). Direct correlation was found between TNF-α and RIPA (r 
= +0.28; p<0.01) as well as between RIPA and IL-1β (r = +0.26; p<0.05), they 
were more pronounced than in patients of the comparison group(r = +0.25  and  
r = +0.22 respectively; p<0.05).  
Conclusion. Patients with EH in conditions of comorbid course with DPU 
have changes of cytokine profile with predominance of pro-inflammatory Ck. 
Presence of correlation relationships between pro-inflammatory Ck and indices 
of endothelial dysfunction, pro-inflammatory Ck and risk-marker of 
thrombogenic complications reflect their community in the mechanisms of 
comorbid pathology formation. It should be considered as burdening criterion in 
conditions of comorbid course of EH and DPU. 
Prospects for further research. Revealed features of the changes of 
immune and metabolic indices expect carrying out of further study of their 
connection with hemostasis factors for refinement of possible role in 
mechanisms thrombogenesis’ development in the patients with comorbid course 
of EH. 
Recommendations. It is necessary to take into account results of this 
study during stratification risk-factors in patients with EH in conditions of 
comorbid course.   
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